BAC
Bank of America Corporation
BAC has the edge over ESNT overall, supported by stronger fundamentals and stronger valuation.
ESNT
Essent Group Ltd.
ESNT trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
ESNT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
ESNT's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like ESNT.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over ESNT in the historical PE scenario, which offers more potential upside but is not a forecast.
ESNT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.7x | $41.50 | -36% |
| Fair | 8.4x | $61.43 | -5.3% |
| Forward | 8.6x | $64.89 | — |
| Current | 8.9x | $64.89 | — |
| Expensive | 9.5x | $69.56 | +7.2% |
Historical ranges are pointers, not guarantees.
ESNT's PE is in its fair range at 8.8x. If earnings grow as analysts expect, today's price would be 8.6x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over ESNT on the outlook, with more favorable valuation and profitability expectations.
ESNT Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for ESNT, but weaker profitability.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over ESNT on earnings, with more consistent year-over-year improvement.
ESNT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.56 | +3.1% |
| Q3 2026 | $7.33 | +6.5% |
| Q2 2026 | $7.18 | +4.7% |
| Q1 2026 | $7.03 | +2.8% |
| Q4 2025 | $6.90 | +0.7% |
| Q3 2025 | $6.88 | -0.3% |
| Q2 2025 | $6.86 | -0.7% |
| Q1 2025 | $6.84 | +3.5% |
| Q4 2024 | $6.85 | +5.4% |
ESNT earned $7.33 per share over the past year, up 6.5% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over ESNT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
ESNT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $374.2M | +20% |
| Q2 2026 | $362.7M | +14% |
| Q1 2026 | $336.1M | +5.8% |
| Q4 2025 | $312.4M | -0.8% |
| Q3 2025 | $311.8M | -1.5% |
| Q2 2025 | $319.1M | +2% |
| Q1 2025 | $317.6M | +6.4% |
| Q4 2024 | $315M | +6% |
ESNT's revenue is growing: $374M last quarter, up 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 53% | -11 points |
| Q2 2026 | 64% | -8.9 points |
| Q1 2026 | 62% | -3.7 points |
| Q4 2025 | 59% | -2.8 points |
| Q3 2025 | 64% | -1.7 points |
| Q2 2025 | 72% | -4 points |
| Q1 2025 | 65% | -6.5 points |
| Q4 2024 | 62% | -6.4 points |
ESNT has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
ESNT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $237.9M | +13% |
| Q2 2026 | $196.1M | +3.9% |
| Q1 2026 | $191.2M | -14% |
| Q4 2025 | $228M | +0.9% |
| Q3 2025 | $210.6M | -7.9% |
| Q2 2025 | $188.8M | +0.6% |
| Q1 2025 | $221.3M | +4.2% |
| Q4 2024 | $226M | +5.9% |
ESNT has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
ESNT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.8% | -1.6M shares |
| 1 year | -8.9% | -8.7M shares |
| 3 years | -16% | -17.3M shares |
| 5 years | -19% | -21.6M shares |
| Available history | -8.7% | -8.6M shares |
ESNT has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $74.5M |
| Q2 2026 | $191.8M |
| Q1 2026 | $170.9M |
| Q4 2025 | $126.2M |
| Q3 2025 | $122.1M |
| Q2 2025 | $170.5M |
| Q1 2025 | $168.9M |
| Q4 2024 | $66.3M |
ESNT spent $563M buying back its own shares over the past year, up 6.7% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
ESNT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.4x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.4x | Very low |
ESNT has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
ESNT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.8 | Neutral |
| Stochastic | 55.2 | Neutral |
ESNT's weekly RSI is 51 (neutral) and its Stochastic is 55 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
ESNT PE vs Financial Services Sector
| Metric | ESNT | Sector median | Relative |
|---|---|---|---|
| PE | 8.9x | 13x | 32% below |
| PE % | 64 | 63 | 1 pt above |
ESNT has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
ESNT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $64.2 | 1.1% above |
| 20 week MA | $66.0 | 1.7% below |
| 50 week MA | $63.2 | 2.7% above |
| 100 week MA | $60.9 | 6.5% above |
| 200 week MA | $56.4 | 15% above |
ESNT has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
ESNT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $52.3 | $43.9 | -16% |
| 2021 | $43.9 | $44.5 | +1.3% |
| 2022 | $44.5 | $39.0 | -12% |
| 2023 | $39.0 | $52.7 | +35% |
| 2024 | $52.7 | $54.1 | +2.5% |
| 2025 | $54.1 | $65.9 | +22% |
| 2026 YTD | $65.9 | $64.9 | -1.5% |
ESNT has the edge over BAC on returns for 2026, with the stronger performance.